SEQUA — Sequana Medical NV Share News
0.000.00%
HealthcareHighly SpeculativeMicro Cap
Brief: Sequana Medical Announces New Share Capital Amount And New Number Of Shares
Brief: Sequana Medical Successfully Raises EUR 15.78 Million In An Equity Placement
Brief: Sequana Medical Launches Equity Offering To Extend Cash Runaway
Brief: Sequana Medical Submits Investigational New Drug Application For DSR® 2.0
Refile: BRIEF-Sequana Announces Added Patents For DSR In China, U.S.
Brief: Sequana Medical: Positive Results From Phase 1 Clinical Trial Of Second-Generation DSR Product
Brief: Sequana Medical FY EBIT Loss Widens To €28.09 Million
Brief: Sequana Medical: Completion Of Pre-Clinical Studies With Second-Generation DSR Product For Congestive Heart Failure
Brief: Sequana Medical Announces Grant Of Additional DSR Patent In US
Brief: Sequana Medical: Positive Top-Line Results From SAHARA Ph.2A Study Of DSR 1.0
Brief: Sequana Medical Announces Positive Top-Line Results From The North American Pivotal Alfapump® Study (POSEIDON)
Brief: Sequana Medical H1 EBIT Loss Widens To 13.3 Mln
Brief: Sequana Medical Secures EUR 10 Million Loan Facility With Kreos Capital
Brief: Sequana Medical Completes Enrollment In Phase 2A Sahara I DSR Study
Brief: Sequana Medical FY Net Loss Widens To EUR 23.6 Million
Brief: Sequana Completes alfapump Implantations In POSEIDON
Brief: Sequana Medical Issues 5,167,268 New Shares
Brief: Sequana Medical Receives New European Medical Device Regulation Certification
Brief: Sequana Medical Announces New Share Capital Amount And New Number Of Shares